All In Biotech

Drug Trial Radar · NCT07144163

A Study to Evaluate Atumelnant in Adults With Congenital Adrenal Hyperplasia

A Randomized, Double-Blind, Multicenter, Placebo-Controlled Study to Evaluate the Safety and Efficacy of Atumelnant in Adult Participants With Classic Congenital Adrenal Hyperplasia (Calm-CAH)

Last checked: Nov 19, 2026Latest source record: Nov 10, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

RecruitingPivotal-lookingPhase 3. Randomized with 150 participants. This is a heuristic, not a regulatory label.

Status

Recruiting

Enrollment

150

Planned (sponsor's estimate)

Start

Dec 11, 2025

Primary completion

May 2027

Study completion May 2027

Sponsor

Lead sponsor
Crinetics Pharmaceuticals Inc.Industry
Sponsor type
Industry
First posted
Aug 27, 2025

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Triple (participant, care provider, investigator)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years, up to 74 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this study is to evaluate the efficacy, safety, PK, and PD of atumelnant in adults with classic CAH due to 21-OHD.

Conditions

  • Congenital Adrenal Hyperplasia
  • Classic Congenital Adrenal Hyperplasia

Interventions

  • AtumelnantDrug

    Atumelnant, tablets, once daily by mouth

  • PlaceboDrug

    Placebo, tablets, once daily by mouth

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Proportion of participants with morning post-GC A4 ≤ ULN who are on physiologic GC replacement.Time frame: Week 32

Locations

82 sites in 15 countries. Site status is shown where the registry gives one.

  • Crinetics Study Site

    Los Angeles, California · Recruiting

  • Crinetics Study Site

    Aurora, Colorado · Recruiting

  • Crinetics Study Site

    Gainesville, Florida · Recruiting

  • Crinetics Study Site

    Atlanta, Georgia · Recruiting

  • Crinetics Study Site

    Chicago, Illinois · Recruiting

  • Crinetics Study Site

    Baltimore, Maryland · Recruiting

  • Crinetics Study Site

    Ann Arbor, Michigan · Recruiting

  • Crinetics Study Site

    Minneapolis, Minnesota · Recruiting

  • Crinetics Study Site

    Rochester, Minnesota · Recruiting

  • Crinetics Study Site

    New Brunswick, New Jersey · Recruiting

  • Crinetics Study Site

    Philadelphia, Pennsylvania · Recruiting

  • Crinetics Study Site

    Pittsburgh, Pennsylvania · Recruiting

  • Crinetics Study Site

    Dallas, Texas · Recruiting

  • Crinetics Study Site

    Charlottesville, Virginia · Recruiting

  • Crinetics Study Site

    Milwaukee, Wisconsin · Recruiting

  • Crinetics Study Site

    Buenos Aires, Buenos Aires F.D., Argentina · Recruiting

  • Crinetics Study Site

    Buenos Aires, Buenos Aires F.D., Argentina · Recruiting

  • Crinetics Study Site

    CABA, Buenos Aires F.D., Argentina · Recruiting

  • Crinetics Study Site

    CABA, Buenos Aires F.D., Argentina · Recruiting

  • Crinetics Study Site

    Córdoba, Córdoba Province, Argentina · Recruiting

  • Crinetics Study Site

    Herston, Queensland, Australia · Recruiting

  • Crinetics Study Site

    Woolloongabba, Queensland, Australia · Recruiting

  • Crinetics Study Site

    Adelaide, South Australia, Australia · Recruiting

  • Crinetics Study Site

    Parkville, Victoria, Australia · Recruiting

  • Crinetics Study Site

    Nedlands, Western Australia, Australia · Recruiting

  • Crinetics Study Site

    Vienna, Austria · Recruiting

  • Crinetics Study Site

    Graz, Styria, Austria · Recruiting

  • Crinetics Study Site

    Fortaleza, Ceará, Brazil · Recruiting

  • Crinetics Study Site

    Brasília, Federal District, Brazil · Recruiting

  • Crinetics Study Site

    Belo Horizonte, Minas Gerais, Brazil · Recruiting

  • Crinetics Study Site

    Curitiba, Paraná, Brazil · Recruiting

  • Crinetics Study Site

    Rio de Janeiro, Rio de Janeiro, Brazil · Recruiting

  • Crinetics Study Site

    Rio de Janeiro, Rio de Janeiro, Brazil · Recruiting

  • Crinetics Study Site

    Porto Alegre, Rio Grande do Sul, Brazil · Recruiting

  • Crinetics Study Site

    Botucatu, São Paulo, Brazil · Recruiting

  • Crinetics Study Site

    Campinas, São Paulo, Brazil · Recruiting

  • Crinetics Study Site

    Ribeirão Preto, São Paulo, Brazil · Recruiting

  • Crinetics Study Site

    São Paulo, São Paulo, Brazil · Recruiting

  • Crinetics Study Site

    São Paulo, São Paulo, Brazil · Recruiting

  • Crinetics Study Site

    Halifax, Nova Scotia, Canada · Recruiting

Showing 40 of 82 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.